EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Treatment of Relapsed Plasmodium vivax with High-Dose Atovaquone–Proguanil in the Setting of Long-Term Rifampin Use

Basil A McIntosh, Shreena P Advani, Andrea C Morales-Lara, Eli P Wilber

The American Journal of Tropical Medicine and Hygiene · 04.11.2026 · 115 (5) · 1024-1026

DOI: 10.4269/ajtmh.26-0413 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 04.11.2026. Verfasst von Basil A McIntosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Proguanil, Atovaquone, Rifampin, Antimalarials. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 58-year-old man with a past medical history significant for cerebrovascular accident with residual quadriplegia and feeding-tube dependence, latent tuberculosis infection, and prior treated malaria who developed relapsed Plasmodium vivax infection while receiving rifampin-based therapy for latent tuberculosis is discussed. Although standard-dose atovaquone–proguanil remained a reasonable treatment option, an increased-dose regimen was selected given concern that rifampin-induced hepatic enzyme induction would lower atovaquone–proguanil plasma concentrations. The patient was treated with atovaquone–proguanil 2,000 mg/800 mg daily (double the standard dose of both components) for 6 days (double the standard 3-day duration) from hospital day 4 to hospital day 9. Primaquine 30 mg daily (standard dose) was started on hospital day 5 and continued for 14 days. This regimen achieved complete resolution of parasitemia and sustained clinical cure at follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProguanilAtovaquoneRifampinAntimalarialsMalaria, VivaxPlasmodium vivaxHumansMaleMiddle AgedDrug CombinationsRecurrenceTreatment Outcome

Substanzen

ProguanilAtovaquoneRifampinAntimalarialsatovaquone, proguanil drug combinationDrug Combinations

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Pharmacy Services, Grady Health System, Atlanta, Georgia, USA.
  • Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Infectious Diseases, Grady Health System, Atlanta, Georgia, USA.

Zitieren

APA

McIntosh, B. A., Advani, S. P., Morales-Lara, A. C., & Wilber, E. P. (2026). Treatment of Relapsed Plasmodium vivax with High-Dose Atovaquone–Proguanil in the Setting of Long-Term Rifampin Use. The American Journal of Tropical Medicine and Hygiene, 115(5), 1024-1026. https://doi.org/10.4269/ajtmh.26-0413

Vancouver

McIntosh BA, Advani SP, Morales-Lara AC, Wilber EP. Treatment of Relapsed Plasmodium vivax with High-Dose Atovaquone–Proguanil in the Setting of Long-Term Rifampin Use. The American Journal of Tropical Medicine and Hygiene. 2026;115(5):1024-1026. doi:10.4269/ajtmh.26-0413

BibTeX
@article{McIntosh2026,
  author = {McIntosh, Basil A and Advani, Shreena P and Morales-Lara, Andrea C and Wilber, Eli P},
  title = {Treatment of Relapsed Plasmodium vivax with High-Dose Atovaquone–Proguanil in the Setting of Long-Term Rifampin Use},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  volume = {115},
  number = {5},
  pages = {1024--1026},
  doi = {10.4269/ajtmh.26-0413}
}
Kostenlos starten →